Lifeloc Q1 net loss narrows to $153K; SpinDetect mold milestone achieved

Lifeloc Technologies, Inc

2026-Q1 EPS reported -$0.06 revenue$2,293,812

Net revenue $2.294M (+1% YoY), net loss $153K ($0.06/diluted share) vs $293K loss in Q1 2025.
Gross margin improved to 43% from 40%; R&D spend >18% of revenue.
Completed production mold for SpinDetect drug analyzer; first article disks delivered in April.
Closed $500K loan from Chairman and CFO at 10.5% interest, interest-only in 2026, 5-year term.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.